Picture of Hyphens Pharma International logo

1J5 Hyphens Pharma International Balance Sheet

0.000.00%
sg flag iconLast trade - 00:00
HealthcareBalancedSmall CapSuper Stock

Annual balance sheet for Hyphens Pharma International, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.

2019
December 31st
R2020
December 31st
R2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:ARSARSInterim ReportARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments26.227.519.536.523.5
Net Total Accounts Receivable
Net Total Receivables28.723.728.731.141.1
Total Inventory
Prepaid Expenses
Total Current Assets66.668.774.189.792.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment5.954.814.413.024.86
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets80.181.599.2114121
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities33.130.342.640.149.2
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Liabilities36.134.344.545.457.8
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity44.147.254.76963
Total Liabilities & Shareholders' Equity80.181.599.2114121
Total Common Shares Outstanding